Pages

Sunday, December 30, 2012

Baxter To Buy Renal Products Firm For $4B.


The Wall Street Journal Share to FacebookShare to Twitter (12/5, B4, Cimilluca, Subscription Publication) reports that as part of its effort to expand its presence in the growing renal therapy market, Deerfield, Illinois-based Baxter International Inc. announced Share to FacebookShare to Twitter it has entered an agreement to acquire Lund, Sweden-based Gambro for 26.5 billion Swedish kronor ($4 billion). The Journal says Baxter is the world's second, and Gambro is world's third, biggest producer of kidney dialysis products and acute or chronic kidney disease therapies.
        The Chicago Tribune Share to FacebookShare to Twitter (12/4, Frost) reports that Baxter CEO Robert Parkinson "told analysts in a conference call that the acquisition would allow it to grow Gambro's business in emerging and high-growth markets in countries like Brazil and China, where many patients with kidney failure go untreated."
        The pending acquisition is also covered by the New York Times Share to FacebookShare to Twitter (12/5, Scott, Subscription Publication) "Dealbook" blog, theAP Share to FacebookShare to Twitter (12/5), Bloomberg News Share to FacebookShare to Twitter (12/5, Tirrell), Reuters Share to FacebookShare to Twitter (12/5, Sherman, Humer), Forbes Share to FacebookShare to Twitter (12/5, Japsen), theChicago Sun-Times Share to FacebookShare to Twitter (12/5, Knowles), and the Chicago Business Journal Share to FacebookShare to Twitter (12/4).

No comments:

Post a Comment